BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 27379394)

  • 1. ADMET Evaluation in Drug Discovery. 16. Predicting hERG Blockers by Combining Multiple Pharmacophores and Machine Learning Approaches.
    Wang S; Sun H; Liu H; Li D; Li Y; Hou T
    Mol Pharm; 2016 Aug; 13(8):2855-66. PubMed ID: 27379394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. hERG classification model based on a combination of support vector machine method and GRIND descriptors.
    Li Q; Jørgensen FS; Oprea T; Brunak S; Taboureau O
    Mol Pharm; 2008; 5(1):117-27. PubMed ID: 18197627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive support vector machine binary hERG classification model based on extensive but biased end point hERG data sets.
    Shen MY; Su BH; Esposito EX; Hopfinger AJ; Tseng YJ
    Chem Res Toxicol; 2011 Jun; 24(6):934-49. PubMed ID: 21504223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine-learning technique, QSAR and molecular dynamics for hERG-drug interactions.
    Das NR; Sharma T; Toropov AA; Toropova AP; Tripathi MK; Achary PGR
    J Biomol Struct Dyn; 2023; 41(23):13766-13791. PubMed ID: 37021352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADMET evaluation in drug discovery. 12. Development of binary classification models for prediction of hERG potassium channel blockage.
    Wang S; Li Y; Wang J; Chen L; Zhang L; Yu H; Hou T
    Mol Pharm; 2012 Apr; 9(4):996-1010. PubMed ID: 22380484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach using pharmacophore ensemble/support vector machine (PhE/SVM) for prediction of hERG liability.
    Leong MK
    Chem Res Toxicol; 2007 Feb; 20(2):217-26. PubMed ID: 17261034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An accurate and interpretable bayesian classification model for prediction of HERG liability.
    Sun H
    ChemMedChem; 2006 Mar; 1(3):315-22. PubMed ID: 16892366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Catch-22 of Predicting hERG Blockade Using Publicly Accessible Bioactivity Data.
    Siramshetty VB; Chen Q; Devarakonda P; Preissner R
    J Chem Inf Model; 2018 Jun; 58(6):1224-1233. PubMed ID: 29772901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common pharmacophores for uncharged human ether-a-go-go-related gene (hERG) blockers.
    Aronov AM
    J Med Chem; 2006 Nov; 49(23):6917-21. PubMed ID: 17154521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of hERG potassium channel blockage using ensemble learning methods and molecular fingerprints.
    Liu M; Zhang L; Li S; Yang T; Liu L; Zhao J; Liu H
    Toxicol Lett; 2020 Oct; 332():88-96. PubMed ID: 32629073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined receptor and ligand-based approach to the universal pharmacophore model development for studies of drug blockade to the hERG1 pore domain.
    Durdagi S; Duff HJ; Noskov SY
    J Chem Inf Model; 2011 Feb; 51(2):463-74. PubMed ID: 21241063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HergSPred: Accurate Classification of hERG Blockers/Nonblockers with Machine-Learning Models.
    Zhang X; Mao J; Wei M; Qi Y; Zhang JZH
    J Chem Inf Model; 2022 Apr; 62(8):1830-1839. PubMed ID: 35404051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interactions between hERG potassium channel and blockers.
    Du L; Li M; You Q
    Curr Top Med Chem; 2009; 9(4):330-8. PubMed ID: 19442204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADMET Evaluation in Drug Discovery. Part 17: Development of Quantitative and Qualitative Prediction Models for Chemical-Induced Respiratory Toxicity.
    Lei T; Chen F; Liu H; Sun H; Kang Y; Li D; Li Y; Hou T
    Mol Pharm; 2017 Jul; 14(7):2407-2421. PubMed ID: 28595388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling of the hERG K+ Channel Blockage Using Online Chemical Database and Modeling Environment (OCHEM).
    Li X; Zhang Y; Li H; Zhao Y
    Mol Inform; 2017 Dec; 36(12):. PubMed ID: 28857516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSSF-hERG: A machine-learning-based hERG potassium channel-specific scoring function for chemical cardiotoxicity prediction.
    Meng J; Zhang L; Wang L; Li S; Xie D; Zhang Y; Liu H
    Toxicology; 2021 Dec; 464():153018. PubMed ID: 34757159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in computational prediction of HERG blockage.
    Wang S; Li Y; Xu L; Li D; Hou T
    Curr Top Med Chem; 2013; 13(11):1317-26. PubMed ID: 23675938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the potency of hERG K⁺ channel inhibition by combining 3D-QSAR pharmacophore and 2D-QSAR models.
    Tan Y; Chen Y; You Q; Sun H; Li M
    J Mol Model; 2012 Mar; 18(3):1023-36. PubMed ID: 21660488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico prediction of hERG blockers using machine learning and deep learning approaches.
    Chen Y; Yu X; Li W; Tang Y; Liu G
    J Appl Toxicol; 2023 Oct; 43(10):1462-1475. PubMed ID: 37093028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico prediction of hERG inhibition.
    Jing Y; Easter A; Peters D; Kim N; Enyedy IJ
    Future Med Chem; 2015; 7(5):571-86. PubMed ID: 25921399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.